Abstract:Abstract Background The purpose of this study was to investigate the ability of differential diagnosis of prostate specific antigen decline rate (PSADR) per week, degree of prostatic collapse (DPC) and tissue signal rate of prostate (TSRP) between prostatitis and prostate cancer. Methods The clinical data of 92 patients [prostate specific antigen (PSA) > 10 ng/mL] who underwent prostate biopsy in the Department of Urology, the Second Affiliated Hospital of Xi ’an Jiaotong University from May 2017 to April 2020 were reviewed retrospectively. They were divided into two groups, prostatitis group ( n = 42) and prostate cancer (PCa) group ( n = 50), according to pathological results. Parameters, like patient characteristics, PSADR, DPC, TSRP and infectious indicators, were compared and analyzed by t test or non-parametric test to identify if there were significant differences. The thresholds of parameters were determined by the receiver operating characteristic curve (ROC), and the data were analyzed to investigate the diagnostic value in distinguishing of prostatitis and prostate cancer. Results There were statistical differences in age, PSADR, DPC, TSRP, neutrophil percentage in serum, white blood cell (WBC) in urine and prostate volume between prostatitis group and PCa group ( P < 0.001, < 0.001, = 0.001, 0.001, 0.024, 0.014, < 0.001 respectively). There was no statistical difference in serum WBC count, serum neutrophil count, monocyte percentage and urine bacterial count between two groups ( P = 0.089, 0.087, 0.248, 0.119, respectively). Determined by ROC curve, when the thresholds of PSADR per week as 3.175 ng/mL/week, DPC as 1.113, TSRP as 2.708 were cutoffs of distinguishing prostatitis and prostate cancer. When combining these three indexes to diagnose, the accuracy rate of diagnosis of prostatitis was 78.85%, the accuracy rate of diagnosis of prostate cancer was 97.50%. Univariate analysis suggested that PSADR, DPC and TSRP played an important role in differentiating prostate cancer from prostatitis ( P 3.175 might be good indicators when distinguishing prostate disease with prostatitis (OR = 14.305, 95%CI = 3.779 ~ 54.147), while DPC > 1.113 and TSRP > 2.708 might be associated with a higher risk of prostate cancer (OR = 0.151, 95%CI = 0.039 ~ 0.588; OR = 0.012, 95%CI = 0.005 ~ 0.524, respectively). Conclusion The combination of PSADR per week, DPC, and TSRP might be helpful to distinguish prostate cancer and prostatitis, and can reduce unnecessary invasive and histological procedure.

Relationship between serum prostate specific antigen and asymptomatic prostatic inflammation

Applied Research of Prostate Specific Antigen Combined with Prostate Cancer Gene 3 in Diagnosis of Prostate Disease

The effect of patients′ age and prostatic volume on serum prostate specific antigen (PSA) level

Role of Inflammation in Benign Prostatic Hyperplasia Development among Han Chinese: A Population‐based and Single‐institutional Analysis

Prevalence of and risk factors for asymptomatic inﬂammatory (NIH-IV) prostatitis in Chinese men

Tumor necrosis factor-α expression in patients with obstructive benign prostatic hyperplasia is associated with a higher incidence of asymptomatic inflammatory prostatitis NIH category IV and prostatic calcification

Clinical study by using percentage of free PSA to detect prostate cancer in men with total serum PSA 2.6～4.0ng/ml

Clinical Effect Study of Serum PSA Level and Digital Rectal Examination in Guiding the Prostate Biopsy

The inflammation patterns of different inflammatory cells in histological structures of hyperplasic prostatic tissues.

Predictive Factors for Tissue Inflammation in Patients with Benign Prostatic Hyperplasia: A Clinical Prediction Study

Relationships between total/free prostate-specific antigen and prostate volume in Chinese men with biopsy-proven benign prostatic hyperplasia

A preliminary study on the diagnostic value of PSADR, DPC and TSRP in the distinction of prostatitis and prostate cancer

[Relationship of age over 50 years and serum prostate specific antigen in men of Beijing multicentre communities].

Use of Prostate-Specific Antigen to Predict Pathologic Types in Nodular Benign Prostate Hyperplasia

Clinical Study on PSA for the Early Diagnosis of Prostate Cancer

Clinical Performance of Serum Proprostate-Specific Antigen Isoform[-2] Propsa in Prostate Cancer

Study of Prostate Specific Antigen Relevant Parameters in Prostate Cancer by Three-Dimensional Transrectal Ultrasonography

[The Detection Rate of Prostate Cancer in Different Prostate-Specific Antigen (PSA) Levels in Chinese Men].

Variation of serum PSA with age in benign prostatic hyperplasia patients

[Use of Prostate Health Index in Diagnosing Prostate Cancer in Chinese Men].

Multi-Factors Including Inflammatory/Immune, Hormones, Tumor-Related Proteins And Nutrition Associated With Chronic Prostatitis Nih Iiia Plus B And Iv Based On Famhes Project